Ā© Copyright: 2021 IAS – the International AIDS Society
Email: info@ias2021.org
Track A: Basic science
Basiel Cole, Belgium, “In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of residual viremia and rebound viruses”
Track B: Clinical science
Ayokunle Olanrewaju, United States, “A rapid enzymatic assay for selective detection of HIV drugs that indicate long-term and short-term PrEP adherence”
Track C: Prevention science
Johanna Chapin-Bardales, United States, “Gonorrhea and chlamydia prevalence and associated characteristics among transgender women in 5 U.S. cities, NHBS, 2019”
Track D: Implementation science
Thomas Carpino, United States, “HIV risk behaviors among those with and without viral load suppression: findings from population surveys from four African countries”
Maria Paximadis, South Africa, for her active engagement and valuable input to the collaborative research projects at the Research-for-Cure Academy. During the 2020 academy, Maria presented her research on looking for signs of replicant-competent virus in the South African child.
Ā
Isabella Young, United States, “Next generation 3D-printed intravaginal rings for prevention of HIV and unplanned pregnancy”
Carlos Fernando Caceres, Peru, “Early predictors of seroconversion among enrolees in a PrEP program in Brazil, Mexico and Peru ā the IMPREP Demonstration study”
Brendan L. Harney, Australia, “Hepatitis C virus reinfection incidence among gay, bisexual, and other men who have sex with men living with HIV before and after the availability of direct acting antivirals in Australia”
RachelĀ Miller, Canada, “SARS-CoV-2 lockdown associated with expansion of HIV transmission clusters among key populations”
Christ-Dominique Ngassaki-Yoka, Canada, “The circadian clock machinery regulates HIV transcription in CD4+ T cells”
The grantees were selected to respond to CIPHERās strategic focus for the 2021 round of the Grant Programme. This was onĀ service delivery for HIV and related co-infectionsĀ for paediatric and adolescent populations in resource-limited settings, including research on:
The CIPHER Grant Programme is made possible with the support of Founding Sponsor ViiV Healthcare.
The three grantees are: